Where is Alexion located?
United States of America Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare disorders. Alexion’s global headquarters is in Boston, Massachusetts and its Center of Excellence is based in New Haven, Connecticut.
Who took over Alexion?
AstraZeneca
AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases. AstraZeneca’s mega $39 billion takeover of Alexion Pharmaceuticals has come to a close, delivering the British pharma a lucrative portfolio of immunology medicines and a towering presence in rare diseases.
Is Alexion being acquired?
AstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca.
What is Alexion known for?
Alexion Pharmaceuticals, established in 1992, is a renowned global biopharmaceuticals company best known for its Soliris drug used for the treatment of rare disorders such as atypical hemolytic uremic syndrome (aHUS). It has been in the forefront of research into autoimmune diseases.
Where is Alexion Pharmaceuticals headquarters?
Boston, MAAlexion Pharmaceuticals / Headquarters
Is Alexion a good company to work for?
Alexion is a great place to work and really focused on the patients needs. The Mission and Culture inspires all levels and areas of the company engaging employees on its continuous growth.
Who owns Alexion?
AstraZenecaAlexion Pharmaceuticals / Parent organization
What happened to Alxn?
(ALXN) approved the merger with AstraZeneca PLC. The merger closed prior to the market open today July 21, 2021. In anticipation of the closing, the stock was halted immediately following the after-hours session at 8 p.m. on July 20, 2021.
Why did AZ buy Alexion?
Now, AZ’s buying Alexion for its knowledge in immune-mediated diseases. Alexion’s portfolio includes Soliris and Ultomiris, which target C5, a key piece of the immune system. In addition, Alexion’s pipeline includes 11 molecules targeting Factor D, FcRn and others.
Who owns Alexion Pharmaceuticals?
What drugs do Alexion make?
Products
- Soliris.
- Strensiq.
- Kanuma.
When did Alexion move to Boston?
September 2017
Alexion announced in September 2017 it would move its headquarters to Boston from New Haven and was forced to return millions in state aid. State and city officials were stung by the decision, but pointed to the research operations that remained in the Elm City.
Is Alexion a takeover target?
Granted, Alexion Pharmaceuticals isn’t the industry’s most exciting acquisition target, but this deal will most likely work out well for investors in the long run.
When did Alexion buys Portola?
On July 2, 2020, Alexion completed its acquisition of Portola through the merger of Buyer with and into Portola without a vote of Portola’s shareholders pursuant to Section 251(h) of the Delaware General Corporation Law.
What happens to Alexion stock after merger?
In December 2020, AstraZeneca agreed to buy Alexion for $175 per share in cash and stock, valuing the Boston-based company at $39 billion. As per the terms of the deal, Alexion shareholders would receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares or ADSs for each Alexion share.
What happened to my Portola shares?
Portola is now a wholly owned subsidiary of Alexion. The tender offer for all of the outstanding shares of common stock of Portola at a price of $18.00 per share expired as scheduled, one minute following 11:59 p.m., New York City time, on July 1, 2020.
Who bought Portola Pharmaceuticals?
Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals Inc. completed the acquisition of Portola Pharmaceuticals Inc. in a deal worth about $1.41 billion. Boston-based Alexion closed a tender offer to acquire Portola for $18 per share.
What happened to Portola?
In May 2020, Alexion Pharmaceuticals and Portola announced that they had entered into a definitive merger agreement for Alexion to acquire Portola….Portola Pharmaceuticals.
| Type | Public |
|---|---|
| Website | portola.com |